The SPCC
e-learning platform

Login Register
Icona Diagnostics & treatment
Diagnostics & treatment
Icona Digital oncology
Digital oncology
Icona Geriatric oncology
Geriatric oncology
Icona Haemato-oncology
Haemato-oncology
Icona Molecular oncology
Molecular oncology
Icona Nutrition
Nutrition
Icona Supportive care & integrative oncology
Supportive care & integrative oncology
Icona Tumour sites
Tumour sites
Webinar live
Tumour sites
16.06.2026 18:00 CEST
HER2DX: translating biology into care
Aleix Prat, Marta González, Francesco Schettini
CME application in progress
Webinar live
Tumour sites
23.04.2026 18:00 CEST
Escalation or de-escalation? Strategies in HER2+ breast cancer treatment
Alexandru Eniu, Roisin Connolly, Adrienne G. Waks
CME application in progress
Webinar live
Diagnostics & treatment
15.04.2026 18:00 CEST
Innovations, implementation, and access in radioligand therapy for neuro-endocrine tumours
Ken Herrmann, Désirée Deandreis, Christophe Deroose, Nikie Jervis
CME application in progress
Webinar live
Haemato-oncology
09.03.2026 18:00 CET
Minimal Residual Disease in multiple myeloma: future directions and controversies
Carl Ola Landgren, Bruno Paiva, Jesús San-Miguel, Luciano Costa, Suzanne Lentzsch, Elena Zamagni
CME application in progress
Webinar live
Diagnostics & treatment
24.02.2026 18:00 CET
Innovations and clinical advances in radioligand therapy
Antoine Leimgruber, Saverio Braccini, Anne-Laure Giraudet, Niklaus Schaefer
CME accredited
Webinar on demand
Haemato-oncology
11.02.2026 18:00 CET
Minimal Residual Disease in multiple myeloma: foundations and clinical relevance
Carl Ola Landgren, Bruno Paiva, Jesús San-Miguel, Jill Corre, Luciano Costa, Elena Zamagni
CME accredited
Webinar on demand
Tumour sites
02.02.2026 18:00 CET
Optimising the treatment pathway in HER2-positive breast cancer: from neoadjuvant therapy to surgery
Aleksandra Filipovic, Monika Gräser, Gaia Griguolo
CME accredited
Webinar on demand
Tumour sites
22.01.2026 18:00 CET
Highlights from ABC 8 - International Consensus Guidelines for Advanced Breast Cancer management
Alexandru Eniu, Fatima Cardoso, Shani Paluch-Shimon
Webinar on demand
Tumour sites
04.12.2025 18:00 CET
Anti-HER2 therapies: biological mechanisms and toxicity management
Alexandru Eniu, Tal Sella, Paola Zagami
CME accredited
Webinar on demand
Tumour sites
02.12.2025 18:00 CET
Definition of high-risk patients and treatment escalation in EBC: role of pathologists and diagnostics in high-risk definitions and its impact on treatment decisions
Angela DeMichele, Zsuzsanna Varga
CME accredited
Webinar on demand
Digital oncology
26.11.2025 18:00 CET
The secondary use of health data, digital twins to improve clinical trials
Antonio Marra, Mélodie Bernaux, Arsela Prelaj
CME accredited
Webinar on demand
Diagnostics & treatment
10.11.2025 18:00 CET
The urgency to treat with the best treatment options in the first-line MBC setting
Tanja Spanic, Evandro de Azambuja, Esther Sanfeliu
Webinar on demand
Tumour sites
29.10.2025 18:00 CET
How to decide on treatment strategies for high-risk early HR+/HER2- breast cancer
Matti Aapro, Carlos Barrios, Nadia Harbeck
CME accredited